/ /

Fred Gebhart
Engaging OCTA in glaucoma imaging
Engaging OCTA in glaucoma imaging
A prospective, observational study found that eyes with mild POAG could be differentiated from pre-perimetric glaucomatous eyes, which also could be differentiated from normal eyes using OCTA-derived retinal vessel density measurements.
Exploring wider role for premium IOL implantation in glaucoma patients
When it comes to recommending a premium IOL, a patient’s glaucoma is only one factor to consider. Just like any other patient planning cataract surgery, visual needs and preferences for/against glasses are also important factors.
Deeper implantation depth for inlay may enhance visual performance
A comparative analysis suggests placement of a cornea inlay (Kamra, AcuFocus) has improved patient satisfaction, refractive stability, and visual results when placed at 250 μm or deeper in the cornea. Shallower implantation depths may be more prone to refractive instability and lower patient satisfaction.
New IOL offers full-distance, good intermediate distance
Presbyopia patients have changed. They are younger than ever, more active than ever before, and they have more treatment options than ever before.
Next-generation phaco system design improves stability, reduces energy
Los Angeles ophthalmologist Mitchell Shultz, MD, shares some of his clinical experience with a next-generation phacoemulsification platform (Stellaris Elite, Bausch + Lomb). The new platform received 510(k) clearance from the FDA in April.
WFG diagnostic capabilities take entire optical system into account
Advancements in wavefront-guided technology include improved resolution that provides not only better spot quality but also the ability to scan highly aberrated eyes that often did not produce treatable images using earlier technology, according to Edward E. Manche, MD.
Phyician-patient dynamic reshaped in era of EHR
Is your electronic health record (EHR) less than magical? Part of the problem may be how you are using it.
Bimatoprost insert offers noninvasive platform for early glaucoma patients
A 19-month, open-label study of a novel bimatoprost, sustained-release ocular insert shows good safety and efficacy. The insert is polymer ring that sits atop the eye in the conjunctival fornix. Phase III trials are expected to begin in 2017.
Expanded line of 27-gauge instruments advantageous
Expanded line of 27-gauge instruments advantageous
The portfolio of retinal instruments continues to expand with a growing line of tools offering surgeons improved work efficiency while promoting better surgical outcomes with 27-gauge instruments.
Rochester University researcher awarded 2017 Shaffer Prize
For his research efforts to better understand the molecular pathways that are responsible for axonal degeneration in glaucoma, Richard Libby, PhD, was awarded the 2017 Shaffer Prize for Research during Thursday night’s Glaucoma 360 annual Gala.